EZH2 also exhibits non-catalytic and PRC2-independent roles in stabilizing DNA damage binding protein 2 (DDB2) to facilitate nucleotide excision repair (NER) and control cisplatin resistance in SCLC (61). This evidence concerns the gene DDB2 and small cell lung carcinoma.